VALIANT LABORATORIES Financial Statement Analysis
|
||
The Revenues of VALIANT LABORATORIES have decreased by -45.48% YoY .
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by -99.21 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
VALIANT LABORATORIES Last 5 Annual Financial Results
[BOM: 543998|NSE : VALIANTLAB]
Consolidated | Mar2024 | Mar2023 |
---|---|---|
Revenues | ₹182 Cr | ₹334 Cr |
Expenses | ₹190 Cr | ₹299 Cr |
Operating Profit (Excl OI) | ₹-8.41 Cr | ₹35 Cr |
Other Income | ₹9.68 Cr | ₹4.89 Cr |
Interest | ₹0.08 Cr | ₹0.25 Cr |
Depreciation | ₹1.97 Cr | ₹1.56 Cr |
Profit Before Tax | ₹-0.77 Cr | ₹38 Cr |
Profit After Tax | ₹0.32 Cr | ₹29 Cr |
Consolidated Net Profit | ₹0.32 Cr | ₹29 Cr |
Earnings Per Share (Rs) | ₹0.07 | ₹8.91 |
PAT Margin (%) | 0.18 | 8.68 |
ROE(%) | 0.19 | 28.86 |
ROCE(%) | -0.29 | 24.01 |
Total Debt/Equity(x) | 0.32 | 0.59 |
Key Financials |
||
Market Cap | : | ₹ 490.6 Cr |
Revenue (TTM) | : | ₹ 133.4 Cr |
Net Profit(TTM) | : | ₹ -2.2 Cr |
EPS (TTM) | : | ₹ -0.5 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
VALIANT LABORATORIES | -1.1% | 10.6% | -17.4% |
SUN PHARMACEUTICAL INDUSTRIES | 0.9% | -0.1% | 10.9% |
DIVIS LABORATORIES | 3.7% | 3% | 46.5% |
CIPLA | 0.2% | 2.8% | 1.6% |
TORRENT PHARMACEUTICALS | 7.3% | 7.4% | 19.8% |
DR REDDYS LABORATORIES | -4% | 2.6% | 7.2% |
MANKIND PHARMA | 0.6% | -6.1% | 9.3% |
ZYDUS LIFESCIENCES | 2.6% | 6.4% | -8% |
LUPIN | 0.4% | -1.1% | 22.2% |
VALIANT LABORATORIES Revenues
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | -45.48 % |
5 Yr CAGR | -45.48 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹182 Cr | -45.48 | |
Mar2023 | ₹334 Cr | - |
VALIANT LABORATORIES Operating Profit
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-8.41 Cr | Negative | |
Mar2023 | ₹35 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | -4.62% | Negative | |
Mar2023 | 10.5% | - |
VALIANT LABORATORIES Profit After Tax
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | -98.90 % |
5 Yr CAGR | -98.90 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹0.32 Cr | -98.90 | |
Mar2023 | ₹29 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -97.93 % |
5 Yr CAGR | -97.93 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 0.18 % | -97.93 | |
Mar2023 | 8.68 % | - |
VALIANT LABORATORIES Earnings Per Share (EPS)
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | -99.21 % |
5 Yr CAGR | -99.21 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹0.07 | -99.21 | |
Mar2023 | ₹8.91 | - |
VALIANT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | -0.29% | Negative | |
Mar2023 | 24.01% | - |
VALIANT LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹113.1 |
Current MarketCap | : | ₹ 490.6 Cr |
Updated EOD on | : | Jun 30,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -1.1% |
10.6% |
-17.4% |
SENSEX | 2.1% |
2.4% |
7.1% |
VALIANT LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about VALIANT LABORATORIES Financials
How the annual revenues of VALIANT LABORATORIES have changed ?
The Revenues of VALIANT LABORATORIES have decreased by -45.48% YoY .
How the Earnings per Share (EPS) of VALIANT LABORATORIES have changed?
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by -99.21 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs